DE60324471D1 - Verfahren und verwendungszwecke der integrin alpha 10 kette zur diagnose und nachweis von atherosklerotischer plaquebildung in vitro - Google Patents

Verfahren und verwendungszwecke der integrin alpha 10 kette zur diagnose und nachweis von atherosklerotischer plaquebildung in vitro

Info

Publication number
DE60324471D1
DE60324471D1 DE60324471T DE60324471T DE60324471D1 DE 60324471 D1 DE60324471 D1 DE 60324471D1 DE 60324471 T DE60324471 T DE 60324471T DE 60324471 T DE60324471 T DE 60324471T DE 60324471 D1 DE60324471 D1 DE 60324471D1
Authority
DE
Germany
Prior art keywords
atherosclerotic plaque
detection
antigen
vitro
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60324471T
Other languages
English (en)
Inventor
Evy Lundgren-Akerlund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cartela R&D AB
Original Assignee
Cartela R&D AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0201844A external-priority patent/SE0201844D0/xx
Application filed by Cartela R&D AB filed Critical Cartela R&D AB
Application granted granted Critical
Publication of DE60324471D1 publication Critical patent/DE60324471D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60324471T 2002-06-17 2003-06-16 Verfahren und verwendungszwecke der integrin alpha 10 kette zur diagnose und nachweis von atherosklerotischer plaquebildung in vitro Expired - Fee Related DE60324471D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38874702P 2002-06-17 2002-06-17
SE0201844A SE0201844D0 (sv) 2002-06-17 2002-06-17 New methods and use
PCT/SE2003/001012 WO2003105886A2 (en) 2002-06-17 2003-06-16 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation

Publications (1)

Publication Number Publication Date
DE60324471D1 true DE60324471D1 (de) 2008-12-11

Family

ID=29738562

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60324471T Expired - Fee Related DE60324471D1 (de) 2002-06-17 2003-06-16 Verfahren und verwendungszwecke der integrin alpha 10 kette zur diagnose und nachweis von atherosklerotischer plaquebildung in vitro

Country Status (8)

Country Link
US (2) US20050255182A1 (de)
EP (1) EP1589986B1 (de)
JP (1) JP2006510576A (de)
AT (1) ATE412420T1 (de)
AU (1) AU2003239030A1 (de)
CA (1) CA2488423A1 (de)
DE (1) DE60324471D1 (de)
WO (1) WO2003105886A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003239016B2 (en) * 2002-06-14 2007-09-20 Xintela Ab Marker for stem cells and its use
RU2007118385A (ru) 2004-11-22 2008-12-27 Джи-И Хелткер АС (NO) Контрастные агенты для направлений доставки во внеклеточный матрикс
CA2644118A1 (en) * 2006-03-03 2007-09-13 Activbiotics, Inc. Treatment of atherosclerotic disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014432A1 (en) * 1995-10-18 1997-04-24 Cor Therapeutics, Inc. Modulation of integrin-mediated signal transduction
US6458590B1 (en) * 1997-08-07 2002-10-01 The United States Of America, As Represented By The Department Of Health And Human Services Methods and compositions for treatment of restenosis
ES2396693T3 (es) * 1998-04-02 2013-02-25 Xintela Ab Heterodímero de integrina y subunidad del mismo
SE0301087D0 (sv) * 2003-04-14 2003-04-14 Cartela Ab New monoclonal antibody

Also Published As

Publication number Publication date
JP2006510576A (ja) 2006-03-30
EP1589986A2 (de) 2005-11-02
AU2003239030A1 (en) 2003-12-31
CA2488423A1 (en) 2003-12-24
US20080159956A1 (en) 2008-07-03
WO2003105886A3 (en) 2007-11-01
US20050255182A1 (en) 2005-11-17
WO2003105886A2 (en) 2003-12-24
EP1589986B1 (de) 2008-10-29
ATE412420T1 (de) 2008-11-15

Similar Documents

Publication Publication Date Title
DE69836888D1 (de) Verfahren für Fluoreszenzerkennungstest
EE05675B1 (et) Meetod konformse haiguse diagnoosimiseks v?i tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade
BR9810263A (pt) Processo para avaliar artigos absorventes
ATE403745T1 (de) Verfahren zur bestimmung der suzeptibilität zur sepsisentwicklung und arzneimittel zur behandlung von sepsis
DE50015973D1 (de) Messgerät mit Seilsonde und Verfahren zum Kürzen der Seilsonde
WO2002041842A3 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
ATE404118T1 (de) System für kontinuierliche leistungstests
ATE282831T1 (de) Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente
DE59813579D1 (de) Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen
DE60324471D1 (de) Verfahren und verwendungszwecke der integrin alpha 10 kette zur diagnose und nachweis von atherosklerotischer plaquebildung in vitro
ATE422334T1 (de) System und verfahren zur gewebeanalyse
DE60216570D1 (de) Verfahren zum nachweis von alzheimer-krankheit
DE60336128D1 (de) Its durch modulation der methankonzentration im darm
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
EP1134542A3 (de) Vorrichtung zur Prüfung und/oder Vermessung von Prüflingen
BR0007702A (pt) Método e kit de diagnóstico para diagnose de endometriose
BRPI0704641A2 (pt) kit de teste rápido e método para detecção e localização de úlceras e outros sangramentos do trato digestivo em equinos utilizando anticorpos monoclonais e policlonais de hemoglobina e albumina equina
ATE437368T1 (de) Verfahren zum prüfen von mit wt1-verbundenen krankheiten
DE50304756D1 (de) Verfaren zur diagnose von neoplasmen
FI951778A0 (fi) Menetelmä allergian toteamiseksi
ATE389179T1 (de) Verfahren und kit zum nachweis von antigenen
ATE397090T1 (de) Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee